<p><em>与会者包括科学、医学和技术领域的领导者：Jack Hidary、Edward Neilan 博士、Shoshana Shendelman 博士、John Greely 博士、Louis Reese 和 Nadia Harhen.</em></p>
<p>, /PRNewswire/ -- 介绍将在 2026 年 2 月 5 日星期四于纽约市举行的首届 Cures Conference。</p>
<p>Cures Conference 汇聚科学家、医生、制药高管、科技领袖和政府官员，利用他们的集体专业知识——突出创新、推动理解、加速治疗开发，并推动实际应用。</p>
<p>小组讨论将包括以下主题：</p>
<ul>
<li>人工智能如何加速创新；</li>
<li>技术进步如何转化为所有人都能获得药物的机会；以及</li>
<li>我们如何改善全球健康结果</li>
</ul>
<p>知名与会者：</p>
<p><strong>Jack Hidary</strong></p>
<p>Jack Hidary 是 SandboxAQ 的首席执行官，专注于人工智能与量子技术交汇处的企业 SaaS 解决方案。</p>
<p><strong>Edward Neilan 博士 MD, PhD</strong> Edward &#34;Ed&#34; Neilan 博士是国家罕见疾病组织（NORD®）的首席医学和科学官。Ed 是一位医生科学家和罕见疾病专家。</p>
<p><strong>Shoshana Shendelman 博士 PhD</strong> Shoshana Shendelman 博士是一位科学家和企业家，创办了多家生物技术公司。她是罕见和被忽视疾病药物开发的先驱。目前，她是哥伦比亚大学医学中心和哥伦比亚大学 Vagelos 医学院顾问委员会的副主席。</p>
<p><strong>John Greally 博士 MD</strong></p>
<p>John Greally 博士是阿尔伯特·爱因斯坦医学院基因组学部的主任；纽约罕见疾病中心（NYCRD）主任；阿尔伯特·爱因斯坦医学院表观基因组中心主任；以及阿尔伯特·爱因斯坦医学院的遗传学和儿科教授。Greally 博士是一位临床遗传学专家，专注于罕见和先天性疾病。</p>
<p><strong>Louis Reese</strong> Lou Reese 是 United Neuroscience 的联合创始人、首席执行官和董事会成员。</p>
<p><strong>Nadia Harhen</strong> Nadia Harhen 是 SandboxAQ 的人工智能模拟总经理。通过将人工智能的多功能性与量子模拟的准确性相结合，她正在彻底改变药物、材料和化学发现的速度和成本。</p>
<p>Cures Conference 将在纽约市百老汇 1170 号的 The Ned 举行。有关更多信息，请访问 https://curesconference.com。请联系 Sam Sohaili，邮箱为 [email protected]，获取注册和出席信息。</p>
<p>媒体咨询：</p>
<p>[email protected]</p>
<p>来源 DMA United</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Rkw2ODY3OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEyMzE3UFJfTkVXU19VU1BSX19fX19GTDY4Njc5?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Rkw2ODY3OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEyMzE3UFJfTkVXU19VU1BSX19fX19GTDY4Njc5"/></p>

<p>首届治疗会议将于 2026 年 2 月 5 日在纽约市举行，汇聚科学家、医生和行业领袖，共同讨论医疗保健领域的创新。主要议题包括人工智能在加速创新和改善全球健康结果中的作用。值得注意的讨论嘉宾包括 Jack Hidary、Edward Neilan 博士和 Shoshana Shendelman 博士等。此次活动旨在利用集体专业知识推动治疗开发和实际应用</p>

<p><em>Panelists include leaders in the fields of science, medicine and technology: Jack Hidary, Dr. Edward Neilan, Dr. Shoshana Shendelman, Dr. John Greely, Louis Reese and Nadia Harhen.</em></p>
<div class="lb-trans"><p><em>与会者包括科学、医学和技术领域的领导者：Jack Hidary、Edward Neilan 博士、Shoshana Shendelman 博士、John Greely 博士、Louis Reese 和 Nadia Harhen.</em></p>
</div><p>, /PRNewswire/ -- Introducing the inaugural Cures Conference to be held in NYC on Thursday, February 5, 2026.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- 介绍将在 2026 年 2 月 5 日星期四于纽约市举行的首届 Cures Conference。</p>
</div><p>The Cures Conference convenes scientists, physicians, pharmaceutical executives, tech leaders, and government officials to leverage their collective expertise—highlighting innovations, advancing understanding, accelerating treatment development, and driving real-world implementation.</p>
<div class="lb-trans"><p>Cures Conference 汇聚科学家、医生、制药高管、科技领袖和政府官员，利用他们的集体专业知识——突出创新、推动理解、加速治疗开发，并推动实际应用。</p>
</div><p>Panel discussions will include topics such as:</p>
<div class="lb-trans"><p>小组讨论将包括以下主题：</p>
</div><ul>
<li>How artificial intelligence can accelerate innovation;</li>
<li>How advances in technology can translate to access to medicines for all; and</li>
<li>How we can improve health outcomes globally</li>
</ul>
<div class="lb-trans"><ul>
<li>人工智能如何加速创新；</li>
<li>技术进步如何转化为所有人都能获得药物的机会；以及</li>
<li>我们如何改善全球健康结果</li>
</ul>
</div><p>Noted Panelists:</p>
<div class="lb-trans"><p>知名与会者：</p>
</div><p><strong>Jack Hidary</strong></p>
<div class="lb-trans"><p><strong>Jack Hidary</strong></p>
</div><p>Jack Hidary is the CEO of SandboxAQ, with a focus on enterprise SaaS solutions at the convergence of AI and Quantum tech.</p>
<div class="lb-trans"><p>Jack Hidary 是 SandboxAQ 的首席执行官，专注于人工智能与量子技术交汇处的企业 SaaS 解决方案。</p>
</div><p><strong>Dr. Edward Neilan MD, PhD</strong> Dr. Edward &#34;Ed&#34; Neilan is the Chief Medical and Scientific Officer of the National Organization for Rare Disorders (NORD®). Ed is a physician-scientist and rare disease expert.</p>
<div class="lb-trans"><p><strong>Edward Neilan 博士 MD, PhD</strong> Edward &#34;Ed&#34; Neilan 博士是国家罕见疾病组织（NORD®）的首席医学和科学官。Ed 是一位医生科学家和罕见疾病专家。</p>
</div><p><strong>Dr. Shoshana Shendelman PhD</strong> Dr. Shoshana Shendelman is a scientist and entrepreneur who has founded numerous biotech companies. She is a pioneer in the development of drugs for rare and underserved diseases. Currently she is Vice Chair of the Board of Advisors at Columbia University Medical Center and Columbia University Vagelos College of Physicians and Surgeons.</p>
<div class="lb-trans"><p><strong>Shoshana Shendelman 博士 PhD</strong> Shoshana Shendelman 博士是一位科学家和企业家，创办了多家生物技术公司。她是罕见和被忽视疾病药物开发的先驱。目前，她是哥伦比亚大学医学中心和哥伦比亚大学 Vagelos 医学院顾问委员会的副主席。</p>
</div><p><strong>Dr. John Greally MD</strong></p>
<div class="lb-trans"><p><strong>John Greally 博士 MD</strong></p>
</div><p>Dr. John Greally is the Chief of the Division of Genomics, at Albert Einstein College of Medicine; Director, New York Center for Rare Diseases (NYCRD); Director, Center for Epigenomics, Albert Einstein College of Medicine; and Professor of Genetics and Pediatrics, Albert Einstein College of Medicine. Dr. Greally is a specialist in clinical genetics, with an emphasis on rare and congenital diseases.</p>
<div class="lb-trans"><p>John Greally 博士是阿尔伯特·爱因斯坦医学院基因组学部的主任；纽约罕见疾病中心（NYCRD）主任；阿尔伯特·爱因斯坦医学院表观基因组中心主任；以及阿尔伯特·爱因斯坦医学院的遗传学和儿科教授。Greally 博士是一位临床遗传学专家，专注于罕见和先天性疾病。</p>
</div><p><strong>Louis Reese</strong> Lou Reese is a co-founder, CEO and member of Board of Directors at United Neuroscience.</p>
<div class="lb-trans"><p><strong>Louis Reese</strong> Lou Reese 是 United Neuroscience 的联合创始人、首席执行官和董事会成员。</p>
</div><p><strong>Nadia Harhen</strong> Nadia Harhen is the General manager of AI Simulation at SandboxAQ. By combining the versatility of AI with the accuracy of quantum simulation, she is radically shifting the rate and cost of drug, material, and chemical discovery.</p>
<div class="lb-trans"><p><strong>Nadia Harhen</strong> Nadia Harhen 是 SandboxAQ 的人工智能模拟总经理。通过将人工智能的多功能性与量子模拟的准确性相结合，她正在彻底改变药物、材料和化学发现的速度和成本。</p>
</div><p>The Cures Conference will be held at The Ned, 1170 Broadway, New York, New York. For more information, visit https://curesconference.com. Please contact Sam Sohaili at [email protected] for registration and attendance information.</p>
<div class="lb-trans"><p>Cures Conference 将在纽约市百老汇 1170 号的 The Ned 举行。有关更多信息，请访问 https://curesconference.com。请联系 Sam Sohaili，邮箱为 [email protected]，获取注册和出席信息。</p>
</div><p>For Press Inquiries:</p>
<div class="lb-trans"><p>媒体咨询：</p>
</div><p>[email protected]</p>
<div class="lb-trans"><p>[email protected]</p>
</div><p>SOURCE DMA United</p>
<div class="lb-trans"><p>来源 DMA United</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIxJk5ld3NJdGVtSWQ9Rkw2ODY3OSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjEyMzE3UFJfTkVXU19VU1BSX19fX19GTDY4Njc5" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=FL68679&amp;Transmission_Id=202601212317PR_NEWS_USPR_____FL68679&amp;DateId=20260121"/></p>

首届治愈大会定于2026年2月5日星期四在纽约市召开